Top Markets
Coin of the day
Orum Therapeutics, Inc. Orum Therapeutics, Inc.

Orum Therapeutics, Inc.

475830
Peringkat dalam Saham #9664
Orum Therapeutics, Inc. is a biopharmaceutical company dedicated to the... Orum Therapeutics, Inc. is a biopharmaceutical company dedicated to the discovery and development of novel therapeutic solutions for both cancer and immune system conditions. The firm specializes in creating degrader-antibody conjugates, an innovative class of drugs that merges traditional antibody-drug conjugate (ADC) technology with targeted protein degradation. Their flagship product candidate, ORM-1153, functions as a GSPT1 protein degrader, specifically engineered to address hematologic malignancies. Orum Therapeutics was established in 2016 and operates out of Daejeon, South Korea.
Harga Saham
$45.64
Terakhir disinkronkan: 2026-08-28
Kapitalisasi Pasar
$969.02M
Perubahan (1 hari)
-1.20%
Perubahan (1 tahun)
146.66%
Negara
KR
Perdagangan Orum Therapeutics, Inc. (475830)

Kategori

Harga 475830 dengan kapitalisasi pasar B
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
475830
$45.64
Kapitalisasi pasar dari Orum Therapeutics, Inc.(475830)
Kapitalisasi Pasar: $969.02M
Per August 2026, Orum Therapeutics, Inc. memiliki kapitalisasi pasar sebesar $969.02M. Ini menjadikan Orum Therapeutics, Inc. sebagai perusahaan 9664th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Orum Therapeutics, Inc. dari 2025 hingga 2026
475830 dibandingkan dengan 5 teratas stocks paling populer
Harga 475830 Aset B Pasar B Hasil
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
$247,917 $969.02M
$5.264T +543,118.35%
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
$221,420 $969.02M
$4.701T +485,060.24%
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
$196,736 $969.02M
$4.177T +430,974.59%
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
$179,792 $969.02M
$3.817T +393,846.51%
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
$134,998 $969.02M
$2.866T +295,698.99%